FDA hints RU-486 abortion pill could gain license
The FDA says existing European trials may suffice for review and invites an applicant to market RU-486 in the United States. No U S company or manufacturer has yet applied, while Bush era bans on import persist and the Supreme Court upholds them. Wyden calls the letter a path to quick approval amid a heated abortion debate.
MENTIONED IN THIS ARTICLE
Washington
United States
Food and Drug Administration
FDA
Europe
Congress
Roussel Uclaf
Wyden
Carol R. Scheman
Scheman
Bush
Supreme Court
Also Mentioned on This Page
The
Associated Press
Bate
House
Steve Jenning
Bill Clinton
Clinton
Jenning
Atlantic
U.S
Cabot Medical
Langhorne, Pa
Gynex
Vernon
Benjamin Frankili
Gary
Erie
East
Sun
Camillus Mall
Great Northern Mall
Carousel Center
Ieee
Wes
Christian Dior
Ours
Eternity
Calvin Klein
Cologne
Elizabeth Taylor
Liz Claiborne
Giorgio Beverly Hills
Ralph Lauren
G. Mackie
Bob Mackie
H. Joop! Femme
Oscar de la Renta